Navigation Links
New Study Evaluates Psychotropic Prescribing For Persons with Intellectual Disabilities, Other Psychiatric Disorders
Date:11/26/2013

PITTSBURGH, Nov. 26, 2013 /PRNewswire/ -- A new report from Community Care Behavioral Health Organization, published in a recent edition of Psychiatric Services in Advance, shows varying psychotropic prescribing patterns in Medicaid recipients (adults and children) with the co-diagnosis of an intellectual disability and a mental health condition, as well as those with a mental health condition diagnosis only.

"We designed this study in response to stakeholder concerns about the use of psychotropic medication among individuals with an intellectual disability," said Gail A. Edelsohn, MD, MSPH, lead author of the study.

To examine the use of psychotropic medication, the study compared:

  • Prescription patterns for four medication classes between the two groups.
  • The pattern of prescribing three or more psychotropic medications concurrently.

The study raises the question about careful use of psychotropics and the importance of recognizing the underlying causes of challenging behaviors, as well as the use of psychosocial interventions in individuals with intellectual disabilities.  Also, the higher rates of prescriptions for mood stabilizers found in the children's co-diagnosis group raises the question about whether medications are being used as anticonvulsants or to treat behavioral health conditions.

The five-year study includes recommendations for behavioral intervention alternatives and careful monitoring of psychotropic effectiveness and side effects.

The full report can be found at http://ps.psychiatryonline.org/Article.aspx?ArticleID=1777608

About Community Care
Community Care Behavioral Health Organization, a nonprofit, tax-exempt recovery-focused behavioral health managed care organization headquartered in Pittsburgh, Pennsylvania, manages mental health and substance use disorder services for approximately 750,000 Medical Assistance recipients in Pennsylvania. Community Care also serves as the behavioral health organization for the Hudson River Region of New York State. Part of UPMC, Community Care was incorporated in 1996 with a mission to improve the health and well-being of the community through the delivery of effective and accessible behavioral health services.


'/>"/>
SOURCE Community Care Behavioral Health Organization
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-GSK3 Rx and Earns $3 Million Milestone Payment From GSK
2. Seno Medical Instruments Launches Pivotal Study of New Functional Imaging Platform in Breast Cancer Diagnosis
3. Orexigen Announces Successful Interim Analysis of Contrave Light Study
4. Orexigen Therapeutics to Host Contrave Light Study Interim Analysis Conference Call and Webcast
5. New Study by Imaging the World and Philips Demonstrates the Power of Ultrasound Screenings to Transform Maternal and Newborn Care in Rural Uganda
6. Study Results Reveal Oral Growth Hormone Boosting Supplement May Be Capable of Producing the Same Benefits as Synthetic Growth Hormone Injections
7. Irvine Center for Clinical Research Announces Open Enrollment for New Low Testosterone Study
8. Chicago Man Breathes Again Thanks to Northwestern Medicine Study
9. Phase IIb Study of Vanoxerine Shows Strong Safety and Statistically Significant Efficacy Signals for Treatment of Atrial Fibrillation
10. Zafgen Announces New Weight Loss and Safety Data from Phase 2 Study of Beloranib in Obesity at Obesity Week 2013
11. Epizymes EPZ-5676 DOT1L Inhibitor Demonstrates Encouraging Initial Findings in an Ongoing Phase 1 Dose Escalation Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 2017 Research and Markets has announced the ... 2023" report to their offering. ... The ablation device global market is expected ... by 2023. Ablation is the minimally invasive therapeutic ... cancerous or diseased tissue removal, to the removal of abnormally conducting ...
(Date:3/29/2017)... , March 29, 2017  Spiral Therapeutics, Inc. ... with Bionure Farma, S.L. for the worldwide exclusive ... BN119 in the field of otolaryngology for aggregate ... The agreement provides Spiral with the ... a differentiated product profile. Under the terms of ...
(Date:3/29/2017)... --  Royal Philips (NYSE: PHG, AEX: PHIA), ... a company that develops artificial intelligence technology for ... solutions that improve the precision and accuracy of ... partnership aims to build deep learning applications in ... to be applied to massive pathology data sets ...
Breaking Medicine Technology:
(Date:3/29/2017)... Ca (PRWEB) , ... March 29, 2017 , ... ... process in many scientific laboratories. The assembly protocols involve many repetitive steps and ... suited for automation, which enables the high-throughput needed, and results in a lower ...
(Date:3/29/2017)... ... March 29, 2017 , ... Hamlin Dental Group, multi-location ... now offering laser dental treatments. Dental lasers are safe and effective options, and can ... options and can improve the overall quality of care. , Dr. Hamid Reza of ...
(Date:3/29/2017)... ... March 29, 2017 , ... Physicians’ Education Resource® (PER®), ... medical education conference for clinicians who manage some of the most difficult-to-treat forms ... , The program will be led by co- chairs Dr. John Marshall, chief ...
(Date:3/29/2017)... ... March 29, 2017 , ... AvePoint , the Microsoft Cloud expert, is ... Richmond, Virginia, located at the Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating ... Ralph S. Northam and Mayor of Richmond Levar M. Stoney. , Founded in 2001, ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... in order to improve teacher quality, the field must first improve teacher preparation ... popular reform to the next” and that decades of input- and outcome-based research ...
Breaking Medicine News(10 mins):